Rituxirel 500 mg Injection
  1. Home
  2. Pharma Products
  3. Reliance Life Sciences Pvt Ltd
  4. Rituxirel 500 mg Injection

Rituxirel 500 mg Injection

Rituxirel 500 mg Injection contains rituximab 500 mg in a 50 mL vial and is a prescription monoclonal antibody medicine. It targets CD20-positive B cells and is used in certain blood cancers and autoimmune disorders. The medicine is administered by intravenous infusion under medical supervision.

BUY NOW

Category

Rituximab binds to the CD20 antigen present on B-lymphocytes and supports their immune-mediated destruction. Rituxirel is used in conditions including non-Hodgkin lymphoma, chronic lymphocytic leukaemia, and selected autoimmune disorders. The 500 mg presentation contains 10 mg of rituximab per mL, with 500 mg in a 50 mL vial. It is supplied as a concentrate for intravenous infusion and should be handled according to the prescribed treatment protocol.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 500 mg
Concentration 10 mg/mL
Pack Size 50 mL vial
Dosage Form Concentrate for solution for infusion
Route of Administration Intravenous infusion

Product Also Known As

Rituxirel 500 mg Injection, Rituxirel 500 mg/50 mL, Rituxirel Rituximab 500 mg Injection, Rituxirel 500 Injection, Rituximab 500 mg Injection, Rituximab 500 mg/50 mL